Introduction
Organohalogen contaminants (OHCs) are a diverse group of chemicals including organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs). Despite their various applications, these compounds are highly lipophilic, persistent in the environment and capable of bioaccumulation and biomagnification along the food chain. 1, 2 Moreover, numerous toxicological studies have associated different OHCs with adverse health effects including endocrine disruption, reproductive, developmental and neurological toxicity, type 2 diabetes and different types of cancer. [3] [4] [5] [6] Combined with their ubiquitous distribution in almost all biotic and abiotic environmental compartments, these features have led to global concern over the production and use of OHCs. As a result, most OCPs, PCBS and PBDEs are currently listed as persistent organic pollutants (POPs) under the UNEP Stockholm Convention. 1 While the regulatory actions have led to levelling off and even slight decline of the environmental concentrations of various OHCs in different regions, human exposure to these contaminants still occurs via direct and indirect pathways. 7 Several authors have documented the association between certain types of food (e.g. fish) and elevated serum levels of OCPs and PCBs, 8, 9 while others established significant positive correlations between PBDEs in indoor dust and their serum levels. 10 Recently, dermal uptake has been highlighted as a potential pathway of human exposure to PCBs and PBDEs. 11 Due to their relevance for public health and associations with various diseases, several countries have collected extensive data on the occurrence and levels of OHCs in their population. [12] [13] [14] [15] However, very little is known about the concentrations of OHCs in the blood of the Egyptian population. Furthermore, epidemiological studies have raised concerns over the increased incidence of colorectal cancer among the Egyptian M A N U S C R I P T
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4 population, especially that patients under age 40 constitute 35.6% of all colorectal cancer cases in Egypt. 16, 17 Few authors have investigated genetic, dietary and life-style factors as potential determinants for the increased incidence of colorectal cancer in Egypt. Abdel-Rahman et al. reported an association between polymorphisms in the gene for the DNA repair enzyme XRCC1 with increased risk of colorectal cancer among Egyptians. Interestingly, an association between the studied polymorphisms and early age of disease onset was observed. 18 An epidemiological study of cancer of all organ sites in Gharbiah Province of Egypt from 1999 to 2002 revealed higher urban than rural incidences among both men and women for colorectal cancer. 19 This was linked to dietary preferences of the urban population with higher contribution of meat and fat as opposed to vegetables. Dietary risk factors were further highlighted by the results of another study from Minia governorate, where the most significant dietary and lifestyle colorectal cancer risk factors were higher consumption of red meat, preserved food, artificial sweeteners and fast foods. 20 However, the relationship between exposure to chemical environmental contaminants and colorectal cancer in Egypt is yet to be fully explored. This may be partly attributed to the lack of information on the levels of different OHCs in the Egyptian population. Therefore, the aims of the current study are:
(a) to provide first insights into the occurrence and levels of PBDEs, PCBs in addition to some OCPs in serum of Egyptian colorectal cancer patients, (b) to compare the levels of target OHCs in serum of patients to an age-and sex-matched control group, (c) to investigate possible correlations between the levels of OHCs in patients and their age, sex or body mass index (BMI) and finally (d) to compare the levels of target OHCs in the Egyptian serum with those reported from other countries.
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Materials and Methods
Target Compounds
The OHCs investigated in this study include: 
Reagents and chemicals
Solvents and chemicals used for analysis were of HPLC grade (Sigma-Aldrich, St.
Louis, MO 63103 USA). Oasis ® HLB SPE cartridges (6 mL/500 mg, 30 µm) were obtained from Waters (Milford, MA 01757 USA), while empty polypropylene cartridges (3 mL) and corresponding frits were purchased from Supelco (Bellefonte, PA, USA).
Individual standards of OCPs and PCBs were obtained from Dr.Ehrenstorfer Laboratories (Augsburg, Germany), while PBDEs standards were purchased from Wellington Laboratories (Guelph, ON, Canada).
Sample collection
Blood samples (5 mL, n=35) were collected from colorectal cancer patients admitted to The serum was separated by centrifugation, transferred to clean tubes and kept frozen at −20°C until analysis. Cholesterol and triglycerides were determined at the collection clinic using routine laboratory analysis then the value for total lipids (TL) was estimated according to the method of Phillips et al. 21 
Sample extraction and clean-up
Sample extraction and clean-up were performed according to a previously reported method. 22 Briefly, thawed and homogenized serum samples (~3 mL) were spiked with internal standards mixture (BDE-77, BDE-128, 13 The crude extract was cleaned-up over 800 mg of pre-washed silica topped with 100 mg of 10% acid silica packed in 3 mL polypropylene SPE cartridges. PCBs, PBDEs and DDTs were eluted first by 8 mL of hexane, followed by PCP in 10 mL of DCM. The 1 st fraction was evaporated and redissolved in 80 μL of isooctane containing 100 pg/µL of PCB129 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 7 and 13 C-BDE-100 used as recovery determination (syringe) standards (RDS) for quality assurance/quality control (QA/QC) purposes. The 2 nd fraction was derivatized by methylation and finally redissolved in 80 μL of iso-octane containing 100 pg/µL of PCB129 used as RDS. Further details are provided in the SI section.
Gas chromatography/mass spectrometry (GC/MS) analysis
Instrumental analysis of target analytes was performed using a FOCUS GC coupled to a DSQII mass spectrometer (Thermo Fisher Scientific, Austin, TX, USA). Separation of target analytes was achieved on an Agilent DB-5 column (15m x 0.25mm; 0.1 µm). The mass spectrometer was run in selected ion monitoring (SIM) with ion source, quadrupole and mass transfer line temperatures set at 230, 150 and 300 °C, respectively. Further details of the GC/MS methods 22 are provided in the SI section.
QA/QC
A multi-stage QA/QC protocol was adopted to investigate the accuracy and precision of the applied analytical method at different stages. Five-point calibration curves were created for all the analytes with a good linearity (R 2 ≥ 0.986) across the studied concentration range. None of the target compounds was above the detection limit in procedural blanks (n=8) 
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Statistical analysis
Statistical analysis of the data was conducted using Excel (Microsoft Office 2010) and SPSS version 22.0. Statistical distribution within each dataset was evaluated using Kolmogorov-Smirnov goodness of fit tests. The results -combined with visual inspection of frequency diagrams -revealed concentrations in all data sets to deviate significantly from the normal distribution. Hence, further statistical analysis was performed using non-parametric tests (e.g. Wilcoxon signed rank test and Spearman rank order correlation). In all instances, where concentrations were ≤ LOQ, (limit of quantification) concentrations were assumed to equal half the LOQ (Table SI-2) and P values <0.05 were considered significant.
Results and discussion
Occurrence and levels of OHCs in Egyptian serum
All target PCBs, PBDEs and OCPs were detected in the analysed serum samples. A statistical summary of target OHCs concentrations in the analysed samples is provided in Table 1 (the full dataset is given in Table SI-5) . p,p`-DDE was the only target compound to be detected in all the analysed serum samples, with the highest median concentration (131 ng/g lw, n=67). BDE-209 was the least frequently detected contaminant (detection frequency = 36%) with a median concentration below the method LOQ. Interestingly, the OHC contamination profile in patients and control was almost identical. ΣDDT (calculated as p,p`-DDE + p,p`-DDT) showed the highest median contribution to the OHC profile in serum of patients and control (77%), while oxychlordane showed the lowest contribution (1%) (Figure 1 ). This is not dissimilar to previous reports of OHC profiles in serum of non-occupationally exposed adults from
Romania, Belgium, Pakistan, Saudi Arabia, USA and Canada. 12, [22] [23] [24] Predominance of p,p`-DDE as the major OHC in serum has been attributed to a combination of factors including continuous exposure via diet or breast milk, high bioaccumulation potential and biomagnification along the food chain, in addition to long elimination half-life (median t0.5 of p,p`-DDE in human serum was more than 8 years). 25 Moreover, while DDT is listed under the Stockholm Convention on POPs, several countries in Africa, Asia and Latin America still use DDT for vector control. This can halter the international efforts to reduce the global contamination levels with this chlorinated pesticide, due to its environmental persistence and potential for long-range atmospheric transport. In Egypt, DDT was used as a pesticide for cotton fields (1952) (1953) (1954) (1955) (1956) (1957) (1958) (1959) (1960) (1961) (1962) (1963) (1964) (1965) (1966) (1967) (1968) (1969) (1970) (1971) with reported stockpiles of 600 tons. 26 It has been officially prohibited from agricultural use since 1980, and in 1996 a Ministerial Decree prohibited the import and use of multiple pesticides including DDT in Egypt. 26 While the higher levels of p,p`-DDE (the main metabolite of DDT) compared to p,p`-DDT in Egyptian serum (Table 1) is expected given its longer half-life and bioaccumulation potential, the ratio between p,p`-DDT/p,p`-DDE can be used to differentiate between current and historical exposures to this pesticide. 27 The low p,p`-DDT/p,p`-DDE ratio (3.7%) in this study implies high environmental persistence and bioaccumulation (c.f. recent and ongoing intake) as the major sources of DDT exposure. 27 A literature survey revealed one study reporting levels of p,p`-DDE, p,p`-DDT and HCB in Egyptian colorectal cancer patients (n=31) and control (n=17) serum samples collected in 1996. 28 Notwithstanding the caveats related to the analytical methodology applied at this time, the median concentrations of p,p`-DDE, p,p`-DDT and HCB in the current study are approximately half of those reported in 1996. 28 Similarly, Tawfic et al. (Table 1) . This is generally in agreement with the globally observed decrease in the levels of these legacy POPs in the environment and humans as a result of various legislations that ban their production and use. 30 To the authors' knowledge, this is the first study to provide levels of PCP, OxC, and PBDEs in Egyptian serum or any other human matrices, which precludes any discussion of the temporal trends of these contaminants in the Egyptian population.
Comparison of OHC levels in serum of patients and control group
Due to the non-parametric distribution of the generated datasets, Wilcoxon signed rank test was used to compare the differences in median and distribution between the concentrations of target OHCs in colorectal cancer patients and the control group. No statistically significant differences (P>0.05) were observed between the levels of individual target OHCs, ΣPCBs, ΣOCPs, ΣPBDEs and ΣOHCs in serum of colorectal cancer patients and the control group (Table SI- 118, while HCB and p,p'-DDE produced no significant increases in colorectal cancer risk. 31 Similarly, a previous study from Egypt reported no significant differences in levels of p,p'-DDE, p,p'-DDT and HCB, in serum of colorectal cancer patients (n= 31) compared to a healthy control group (n = 17). 28 However, other studies from Tunisia (n = 69, controls = 56 females) and Singapore (n = 60, controls = 60 males) have indicated positive associations between concentrations of p,p'-DDE and various PCBs in serum and the risk of breast and prostate cancers, respectively. 32, 33 Therefore, bearing in mind the relatively small sample number; the lack of significant differences between serum levels of OHCs in colorectal cancer patients and the control group in the current study should be interpreted with caution. More research is required on a larger sample size to confirm these findings.
Factors affecting the levels of OHCs in Egyptian serum
Gender, age and BMI were investigated as potential factors influencing the levels of target OHCs in the studied serum samples. The use of other socio-economic factors (e.g. profession, location, diet, income and education) was not allowed by the Ethics Committee to maintain the anonymity of the study participants.
No statistically significant differences (Wilcoxon signed rank test, P>0.05) were observed between the concentrations of OHCs in the serum of males and females among the colorectal cancer patients and the control group. Therefore, we pooled the results from both males and females to study possible associations between contaminant levels in serum, age and BMI of the study participants in the patients and control group (Table   2) . Results revealed a significant positive correlation between the levels of ΣDDT and the age of the blood donners (Table 2 ). Previous studies from France (n = 386, aged 18- 
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12 Survey), 34 Spain (n= 1259 pregnant women, aged >16 to 40 years), 35 USA (n=192 healthy females, aged 45 to 85 years) 36 and UK (n=153 healthy volunteers, aged 22-80 years) 15 have also reported significant increase of serum DDT concentrations with age. This can be explained by the long half-life and high bioaccumulation potential of DDT, combined with decreased metabolism and elimination of OCPs with increasing age 27 .
Despite its lipophilic nature, published results differ with regard to the association between DDT serum levels and BMI. 12 While ΣDDT was significantly correlated with BMI in the present study, no significant association was observed in French adults (despite half the population with BMI > 25 including 15% with BMI >30). 34 This may be attributable to differences in exposure (e.g. diet) and socioeconomic (e.g. profession)
factors influencing the serum levels of OHCs in different populations. 34 It's worth mentioning that the concentrations of p,p`-DDE in the present study contributed 96 ± 23% and 83 ± 34% to ΣDDT and ΣOCPs, respectively. Therefore, it's reasonable to conclude that the significant positive associations of serum ΣDDT and ΣOCPs with participants age and BMI (Table 2) are driven mainly by the concentrations of p,p`-DDE.
Interestingly, PCP levels, the second largest contributor to serum ΣOCPs, showed a significant positive correlation with ΣDDT concentrations in both the patients and control groups (Table 2 ). There is no clear explanation for this strong correlation. In addition to direct exposure via diet, it has been suggested that PCP in serum can result from HCB metabolism. 23 Since no significant correlation was observed between the levels of ΣDDT and HCB or PCP and HCB in serum (Table 2) , it is likely that the correlation between ΣDDT and PCP concentrations originate from common exposure sources to these two contaminants (e.g. diet).
PCP levels were significantly correlated to BMI in the serum of the control group. A possible explanation for this association is that BMI could alter PCP toxicokinetics and M A N U S C R I P T
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13 accumulation of the compound in body fat resulting in increased internal concentration in obese individuals. 37 HCB levels showed a significant correlation with patients' age (Table 2) , which may be attributable to bioaccumulation resulting in increased serum concentrations with age. 12, 34 Comparison with other countries
The concentrations of target OHCs in the analysed Egyptian serum samples (n=67, patients + control group) were compared to those reported previously from other countries ( Figure 2 and Table SI-6). While we are aware that studies from different countries have targeted various populations (e.g. pregnant women, males, diabetic patients and general population) of different age groups with different lifestyles and habits, we believe that such comparison is beneficial to provide a general perspective of the measured concentrations of target OHCs in human blood from Egypt compared to other parts of the world. This is of particular interest given the global distribution of the studied contaminants and the synchronised international efforts required to minimize exposure and reduce human body burdens of these OHCs.
Median HCB level (5.9 ng/g lw) in Egyptian serum was at the lower end of this contaminant concentrations reported globally. This is consistent with low serum HCB concentrations in other developing countries like Saudi Arabia (n=60, 40 diabetic patients and 20 healthy controls), 24 Pakistan (n=85, 34 mothers, 34 children (3-10 years) and 17 general population) 22 and Bangladesh (n=24 males) . 38 Higher serum HCB concentrations were reported from China (n=26, median = 39 ng/g lw) 39 , Spain (n=2433, median = 34 ng/g lw) 40 and USA (n = 341 males, 15 ng/g lw). 41 This may reflect less historical use of HCB in the developing countries. In Egypt, HCB was detected at concentrations of 4 -93 ng/L in water samples collected at different locations along M A N U S C R I P T
14 the river Nile in 1995. It was also detected at low levels in Egyptian fish (2.5-20 ng/g wet weight) and vegetables (3-9 ng/g wet weight) 42 , indicating dietary intake as the predominant source of human exposure to HCB.
PCBs in Egyptian serum showed a similar profile to that reported from other countries with PCB 138 as the predominant congener (median = 4.93 ng/g lw) followed by PCB 153 (median = 2.83 ng/g lw). However, median serum ΣPCBs in this study (10.36 ng/g lw) was lower than those reported elsewhere (Figure 2 ). This is generally in line with low PCB residues found in the Egyptian terrestrial and aquatic environment, which was attributed to the low industrial profile of the country until the 1970s. 43 Unlike PCBs, the median serum concentration of p,p`-DDE in the current study (131 ng/g lw) was higher than those reported in blood samples from the general population of UK (n=153, 100 ng/g lw) 15 , Belgium (n=204, 64 ng/g lw) 12 and Canada (n= 5000, 63 ng/g lw). 12 DDT was never used for Malaria control in Egypt. However, it was widely applied to treat cotton fields from 1952 to 1971. In the 1970s, DDT usage decreased gradually due to the resistance developed by the cotton leafworm, Spodoptera littoralis , until it was officially prohibited from all agricultural applications in 1980. 26 
DDTs
(dominated by p,p`-DDE) were detected in Egyptian fresh water (3-1048 ng/L), vegetables (1.78-2.82 ng/g), meat (67 ng/g fat) and fish (8-91 ng/g wet weight)
products, indicating widespread contamination of the Egyptian environment with DDT. 42 Fewer studies have reported on the levels of PCP and oxychlordane in serum from different countries. The median serum level of PCP in the current study (229 pg/mL) was lower than those reported in serum samples of pregnant women from the Netherlands (n=69, median = 970 pg/mL) and Sweden (n=15, 2830 pg/mL) 44 as well as M A N U S C R I P T
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Norwegian women (n=281, 771 pg/mL) 9 , but higher than the concentrations reported from Japan (n = 20 males, 140 pg/mL) 45 and Pakistan (130 pg/mL). 22 OxC is the oxidised, relatively more polar metabolite of the pesticide Chlordane, which is more likely to be detected in serum. Median level of OxC in Egyptian serum was below LOQ, (<1.5 ng/g lw) with a detection frequency of 39%. This is consistent with the very low detection frequency of Chlordane in the Egyptian environment. 42 To the authors' knowledge, this is the first study to report PBDE levels in Egyptian serum. BDE-47 was the most frequently detected congener (87%) with the highest median level (0.97 ng/g lw), followed by BDE-99 (77%, 0.61 ng/g lw). This is consistent with previous studies from other countries, indicating exposure to the penta-BDE commercial formulation. 46 Median penta-BDE level (1.9 ng/g lw, sum of congeners 47, 99, 100, 153 and 154) in Egyptian serum was at the lower end of those reported from other countries (Figure 2) . A recent study reported low concentrations of PBDEs in dust samples collected from Egyptian homes (n=17, median penta-BDE = 5.2 ng/g), workplaces (n=9, 11.6 ng/g) and cars (n=5, 35.6 ng/g). 47 Indoor dust was highlighted as the major pathway of human exposure to PBDEs via ingestion and dermal contact. 48 Therefore, the low levels of PBDEs in Egyptian serum samples can be explained by the low concentrations of these flame retardants in Egyptian indoor dust.
BDE-209 (the major congener of the deca-BDE mixture) and BDE-183 (the indicator congener for octa-BDE mixture) were detected in Egyptian serum at lower frequency and concentrations than the penta-BDE congeners (Table 1 ). This may be attributed to the high lipophilicity and molecular weight of these congeners, which is likely to reduce their bioavailability to humans following exposure via indoor dust or diet. Moreover, the short serum half-life of BDE-209 (7-14 days) indicates that the detected levels in serum likely reflect recent exposure of the participants, rather than prolonged chronic M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 16 exposure. 49 Overall, the concentrations of PBDEs detected in Egyptian serum in this study are among the lowest reported worldwide.
Limitations and strengths
The current study doesn't aim and can't qualify to be an epidemiological case-control study. This is mainly due to the ethical restrictions which limited the public disclosure of risk factors to age, gender, and BMI; excluding other known important factors to ensure participant anonymity. In addition, the relatively small sample size combined with the 3 risk factors studied can only detect odds ratios of 4 ~5 (or higher) with sufficient statistical power. Uncertainties in the study also include the degree of representability of the studied samples to the general population given the overall small number of participants and the relatively high average BMI observed for both the patients and control group (Table 1) .
However, this work provides the first human biomonitoring data of various OHCs in the Egyptian population, which significantly augments the current knowledge about the global distribution of these contaminants. Furthermore, due to the general lack of statistically significant differences between the patients and control group, the current paper focuses on characterising the levels and profiles of a broad suite of OHCs in 
Research Highlights
• PBDEs, PCBs and OCPs were determined in 67 human blood samples from Egypt • No significant differences between colorectal cancer patients and control group • ΣDDT and ΣOCPs increased significantly with age and BMI • PBDEs and PCBs in serum of Egyptians are among the lowest worldwide
